Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Doping among adolescent athletes.

C E Yesalis1, M S Bahrke

  • 1Department of Health Policy and Administration, Pennsylvania State University, University Park 16802, USA.

Bailliere'S Best Practice & Research. Clinical Endocrinology & Metabolism
|August 10, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Winning and Performance-Enhancing Drugs-Our Dual Addiction.

The Physician and sportsmedicine·2016
Same author

Forum.

The Physician and sportsmedicine·2016
Same author

Self-Treatment of Gynecomastia in Bodybuilders Who Use Anabolic Steroids.

The Physician and sportsmedicine·2016
Same author

Intramuscular Abscess.

The Physician and sportsmedicine·2016
Same author

Self-Reported Use of Anabolic-Androgenic Steroids by Elite Power Lifters.

The Physician and sportsmedicine·2016
Same author

Use of steroids for self-enhancement: an epidemiologic/societal perspective.

The AIDS reader·2006
Same journal

Inhibin B in the assessment of seminiferous tubular function.

Bailliere's best practice & research. Clinical endocrinology & metabolism·2001
Same journal

Post-Chernobyl thyroid carcinoma in children.

Bailliere's best practice & research. Clinical endocrinology & metabolism·2001
Same journal

Surgical approach to thyroid nodules and cancer.

Bailliere's best practice & research. Clinical endocrinology & metabolism·2001
Same journal

Diagnosis and treatment of medullary thyroid cancer.

Bailliere's best practice & research. Clinical endocrinology & metabolism·2001
Same journal

Management of undifferentiated thyroid cancer.

Bailliere's best practice & research. Clinical endocrinology & metabolism·2001
Same journal

Papillary and follicular thyroid carcinoma.

Bailliere's best practice & research. Clinical endocrinology & metabolism·2001
See all related articles

Adolescents use performance-enhancing drugs for athletic and appearance goals, with limited knowledge on safety beyond anabolic-androgenic steroids (AAS). Societal pressures drive demand, necessitating value shifts to curb adolescent drug use.

Area of Science:

  • Sports Medicine
  • Adolescent Health
  • Pharmacology

Background:

  • Performance-enhancing drug (PED) use, including anabolic-androgenic steroids (AAS), is prevalent among adolescents seeking improved athletic performance and physical appearance.
  • Limited research exists on the safety and efficacy of various PEDs and nutritional supplements used by adolescents, beyond AAS.
  • Societal emphasis on winning and appearance fuels the demand for PEDs in adolescent populations.

Purpose of the Study:

  • To review the current understanding of adolescent performance-enhancing drug use.
  • To highlight the knowledge gaps concerning non-AAS PEDs and supplements.
  • To discuss the societal factors contributing to adolescent PED use.

Main Methods:

  • Literature review of studies on adolescent PED and supplement use.

Related Experiment Videos

  • Analysis of prevalence data for anabolic-androgenic steroid (AAS) use in adolescent males and females.
  • Discussion of current prevention and intervention strategies.

    • Main Results:

    • Anabolic-androgenic steroid (AAS) use is reported by 3-12% of adolescent males and 1-2% of adolescent females.
    • Significant knowledge deficits exist regarding the safety and efficacy of numerous performance-enhancing drugs and nutritional supplements.
    • Current strategies include education, prevention, interdiction, and drug testing.

    Conclusions:

    • Adolescent use of performance-enhancing drugs is a complex issue driven by societal values.
    • Addressing adolescent PED use requires a societal shift away from an overemphasis on winning and appearance.
    • Further research is needed on the safety and efficacy of non-AAS performance enhancers in adolescents.